Table 2 Ovarian stimulation characteristics and outcomes.

From: Elevated progesterone on the trigger day does not impair the outcome of Human Menotrophins Gonadotrophin and Medroxyprogesterone acetate treatment cycles

Characteristic

P (ng/mL)

P Value

<1 (n = 3376)

1–1.5 (n = 531)

1.5–2 (n = 120)

≥2 (n = 79)

Total hMG dose (IU),mean (95%CI)

1931.95(1917.05–1946.85)

2069.52(2032.12–2106.92)

2100.00(2041.20–2158.80)

2081.49(2011.84–2151.14)

<0.001a

Duration of stimulation (d), mean (95%CI)

8.92(8.86–8.92)

9.35(9.22–9.48)

9.51(9.28–9.74)

9.57(9.31–9.84)

<0.001a

Number of oocyte aspirated. mean (95%CI)

15.14(14.82–15.46)

25.62(24.58–26.66)

30.61(28.26–32.96)

30.74(27.57–33.91)

<0.001a

Number of oocyte retrieved, mean (95%CI)

10.38(10.15–10.60)

17.99(17.25–18.73)

20.39(18.85–21.94)

19.84(17.59–22.10)

<0.001a

Oocyte retrieval rate, mean (95%CI)

70.45(69.74–71.16)

72.01(70.45–73.57)

68.79(65.42–72.17)

66.89(62.47–70.93)

NS

Normal fertilization rate, mean (95%CI)

89.79(89.18–90.39)

90.00(88.88–91.13)

88.93(86.37–91.49)

89.38(85.43–93.33)

NS

Embryos frozen, mean (95%CI)

4.15(4.06–4.24)

5.97(5.69–6.26)

6.61(5.90–7.32)

6.43(5.55–7.31)

<0.001a

Top-quality embryos, mean (95%CI)

2.33(2.21–2.45)

2.87(2.59–3.22)

2.44(1.96–2.93)

3.08(2.03–4.13)

<0.05b

Hormones on day of trigger

 FSH (mIU/mL), mean (95%CI)

15.03(14.89–15.17)

16.59(16.24–16.95)

16.15(15.48–16.81)

16.35(16.12–17.29)

<0.001a

 LH (mIU/mL), mean (95%CI)

1.74(1.69–1.80)

1.78(1.66–1.90)

2.10(1.65–2.55)

3.98(1.29–6.67)

<0.001b

 E2 (pg/mL), mean (95%CI)

2844.63(2794.82–2894.44)

4492.73(4387.56–4597.90)

4838.66(4728.63–4948.68)

4412.58(4141.50–4683.67)

<0.001a

  1. Data are presented as the means and 95% confidence interval.
  2. aIndicates group with P < 1 ng/mL versus groups with P between 1–1.5 ng/mL, P between 1.5–2 ng/mL and P ≥ 2 ng/mL.
  3. bIndicates group with P < 1 ng/mL versus group with P ≥ 2 ng/mL.
Back to article page